Report cover image

Smart Hospitality Market Share, Size, Trends, Industry Analysis Report, By Offering; By Deployment Mode (Cloud and On-premises); By End-Use (Hotels, Cruise, Luxury Yachts and Others); By Region; Segment Forecast, 2022 - 2030

Published Sep 01, 2025
Length 124 Pages
SKU # PLRS20470348

Description

The global smart hospitality market size is expected to reach USD 310.44 billion by 2034, according to a new study by Polaris Market Research. The report "" Smart Hospitality Market Share, Size, Trends, Industry Analysis Report, By Offering; By Deployment Mode (Cloud and On-premises); By End-Use (Hotels, Cruise, Luxury Yachts and Others); By Region; Segment Forecast, 2025 - 2034"" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Hoteliers forge a lasting, and increase the chance that they will write a positive review by offering a more personalized travel experience. Creating a distinctive visitor experience increases revenue while enhancing brand reputation and customer loyalty. Through new smart hospitality solutions, hotels have access to data-driven insights and customer behavior to enhance the customer experience through better service to every guest.

Over the projection period, the growing adoption of various advanced technologies in the hospitality industry, using 5G, IoT technology, and A.I., is anticipated to create revenue-generating opportunities. As a result, it is anticipated that adopting such cutting-edge technology would drive growth in the global market. These slashing smart hospitality solutions help hotels improve the quality of their services while improving the guest experience. As a result, there will likely be a greater need for smart hospitality solutions, which will fuel the expansion of the market.

Smart Hospitality Market Report Highlights

The guest-experience sub-segment by solution is anticipated to grow at a high CAGR. It is the guest experience that determines the quality of service provided by a hospitality business. A dissatisfactory experience signals that the hotel needs to make improvements.

The cloud-based dominated the market in 2024. Hotels and restaurants are implementing cloud-based technologies that may change with the market and business dynamics. The demand for a better guest experience, enhanced cost efficiency, and universal access to hoteliers from any remote area will boost the market.

In Asia Pacific, the global market is expected to dominate due to its ability to handle outsourced solutions, and the market for smart hospitality is expected to experience significant growth. Furthermore, it is projected that the extensive construction of contact centers will further fuel the expansion of the smart hospitality sector in the area over the next few years.

major players operating in the global market are Cisco Systems, Honeywell International, IBM Corp., Johnson Controls, NEC Corporation, Oracle Corporation, Schneider Electric, Siemens, Winhotel Solution, Huawei Technologies, Oracle, Johnson Controls, Samsung, Springer-Miller Systems, Control4, Wisuite, Qualsoft Systems, Hospitality Network, Guestline, Cloudbeds, Frontdesk Anywhere, Chris Lewis Group, Xie Zhu, BuildingIQ, Stayntouch, and others.

Polaris Market Research has segmented the smart hospitality market report based on offering, deployment, end use, and region:

By Offering Outlook (Revenue - USD Billion, 2020 - 2034)

Solution

Property Management System

Guest Experience Management System

Integrated Security Management

Facility Management Software

Network Management Software

Point Of Sale Software

Services

By Deployment Mode Outlook (Revenue - USD Billion, 2020 - 2034)

Cloud

On-premises

By End Use Outlook (Revenue - USD Billion, 2020 - 2034)

Hotel

Cruise

Luxury Yachts

Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

124 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. U.S. Small Molecule Drug Discovery Outsourcing Market Insights
4.1. Small Molecule Drug Discovery Outsourcing Market – Market Snapshot
4.2. Small Molecule Drug Discovery Outsourcing Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising research and development expenses
4.2.1.2. Increasing need for drug development
4.2.2. Restraints and Challenges
4.2.2.1. Loss of direct control over critical processes
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Small Molecule Drug Discovery Outsourcing Market Trends
4.6. Value Chain Analysis
5. U.S. Small Molecule Drug Discovery Outsourcing Market, by Workflow
5.1. Key Findings
5.2. Introduction
5.2.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Workflow, 2020-2034 (USD Billion)
5.3. Target Identification & Screening
5.3.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Target Identification & Screening, by Region, 2020-2034 (USD Billion)
5.4. Target Validation & Functional Informatics
5.4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Target Validation & Functional Informatics, by Region, 2020-2034 (USD Billion)
5.5. Lead Identification & Candidate Optimization
5.5.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Lead Identification & Candidate Optimization, by Region, 2020-2034 (USD Billion)
5.6. Preclinical Development
5.6.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
5.7. Others
5.7.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Others, by Region, 2020-2034 (USD Billion)
6. U.S. Small Molecule Drug Discovery Outsourcing Market, by Service
6.1. Key Findings
6.2. Introduction
6.2.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Service, 2020-2034 (USD Billion)
6.3. Chemistry Services
6.3.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Chemistry Services, by Region, 2020-2034 (USD Billion)
6.4. Biology Services
6.4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Biology Services, by Region, 2020-2034 (USD Billion)
7. U.S. Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area
7.1. Key Findings
7.2. Introduction
7.2.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Therapeutics Area, 2020-2034 (USD Billion)
7.3. Respiratory System
7.3.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Respiratory System, by Region, 2020-2034 (USD Billion)
7.4. Pain and Anesthesia
7.4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Pain and Anesthesia, by Region, 2020-2034 (USD Billion)
7.5. Oncology
7.5.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Oncology, by Region, 2020-2034 (USD Billion)
7.6. Ophthalmology
7.6.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Ophthalmology, by Region, 2020-2034 (USD Billion)
7.7. Hematology
7.7.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Hematology, by Region, 2020-2034 (USD Billion)
7.8. Cardiovascular
7.8.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Cardiovascular, by Region, 2020-2034 (USD Billion)
7.9. Endocrine
7.9.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Endocrine, by Region, 2020-2034 (USD Billion)
7.10. Gastrointestinal
7.10.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Gastrointestinal, by Region, 2020-2034 (USD Billion)
7.11. Immunomodulation
7.11.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Immunomodulation, by Region, 2020-2034 (USD Billion)
7.12. Anti-infective
7.12.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Anti-infective, by Region, 2020-2034 (USD Billion)
7.13. Central Nervous System
7.13.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Central Nervous System, by Region, 2020-2034 (USD Billion)
7.14. Dermatology
7.14.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Dermatology, by Region, 2020-2034 (USD Billion)
7.15. Genitourinary System
7.15.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Genitourinary System, by Region, 2020-2034 (USD Billion)
8. U.S. Small Molecule Drug Discovery Outsourcing Market, by End Use
8.1. Key Findings
8.2. Introduction
8.2.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by End Use, 2020-2034 (USD Billion)
8.3. Pharmaceutical & Biotechnology Companies
8.3.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
8.4. Academic Institutes
8.4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Charles River Laboratories
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Curia Global, Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development
10.3. Eurofins Scientific
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Evotec
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. GenScript Biotech
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. Labcorp
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. Oncodesign
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. Pharmaron
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Syngene
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Merck
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.